
This post was just published on ZYX Short Change Alert.
The Phase II for AVP-923 results are positive. Almost every such drug with positive Phase II results has failed in Phase III. However, in the short-term the stock will run and has hit the mental stop if still holding.
The upper band of the target zone was $4.11. The stock went down to $4.31 and then moved up. Those still in the stock and have not exited around $7 should consider exiting on any pullback.
One of the rules is to move stops to break even when there is a reasonable gain.… Please click here or the title below to read more.